Financial News

Week in Review: Shanghai Henlius to File for Hong Kong IPO at Valuation of Over $1 Billion

Deals and Financings   Fosun Pharma plans a Hong Kong IPO for Shanghai Henlius Biotech, its antibody JV subsidiary devoted to novel biotech and biosimilar candidates; GO Therapeutics of Boston signed a $195 million licensing deal with Roche to develop cancer antibodies; last year, Shenzhen Salubris acquired China rights to GO products in return for a $5 million investment; Aohua Endoscopy, a Shanghai endoscopy device maker, raised $44 million in a D round led by Lyfe Capital, a Shanghai healthcare-focused PE firm; HiFiBiO Therapeutics, a US-France-China biopharma, will collaborate with Kite Pharma to discover neoantigen-reactive T cell receptors for cancer; Cellular Biomedicine was granted a license for a next-gen neoantigen-reactive tumor infiltrating lymphocyte technology from the US NIH; Ping An Good Doctor will partner with CR Sanjiu, combining the internet platform with CR Sanjiu's portfolio of OTC and prescription TCM products; Company News   PharmaBlock Sciences of Nanjing, a CDMO, has acquired a GMP compliant manufacturing facility in China from Porton Pharma; Trials and Approvals   CANbridge Pharma of Beijing filed a China NDA for Nerlynx®, which could become the third foreign drug approved in China without a clinical trial; Innovent Biologics of Suzhou reported its anti-CD47 mAb has been approved to start US clinical trials in patients with advanced malignancies and lymphomas. Stock Symbols: (HK: 02196: SHA: 600196) (SWX: ROG) (SHZ: 2294) (NSDQ: CBMG) (HK: 1833) (SZE: 300725) (SZE: 300363) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback